Microsoft Word - DE MC - Capital RX Report- Ammended final 1-15-26

… DS ...................................................................................................... 15 SPECIALTY DRUGS AND PLANS ............................................................................. 15 CONCLUSION ................ …

… Pharmacy Provider Terminations, Pharmacy Provider Non- Renewals, Advertising, Contracts, Discount cards and Specialty Drugs. The following is a summary of exceptions noted during the course of this examination and are noted in the order di …

… nrollments, Pharmacy Provider Terminations, Pharmacy Provider Non-Renewals, Contracts, Discount Cards and Specialty Drugs. METHODOLOGY This examination was performed in accordance with Market Regulation standards established by the Dep …

… sement policy and pricing model includes the primary use of NADAC and a secondary the use of AWP versus WAC for any drugs not paid at NADAC. The Company indicated in response to information requests that it reimburses at a higher rate at A …

… icing model includes the primary use of NADAC and a secondary use of AWP (Average Wholesale Price) versus WAC for any drugs not paid at NADAC. The Company indicated that it reimburses at a higher rate at AWP versus WAC for these secondary …

… eimbursement policy and pricing model includes the primary use of NADAC and a secondary use of AWP versus WAC for any drugs not paid at NADAC. The Company indicated in response to information requests that it reimburses at a higher rate at …

… ursement policy and pricing model includes the primary use of NADAC and a secondary the use of AWP versus WAC for any drugs not paid at NADAC. Please see Chapter 33A, Subchapter II and VII Summary for additional information regarding th …

… tical discount program was active and available to plans and the public to receive discounted pricing on prescription drugs during the examination period. It was noted only two Capital RX plans encompassing 46 claims were related to discou …